Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

• Status: Recruiting
• Trial end date: 2021-12-30
• Target enrollment: 0
• Participant gender: All

Summary

The present research will help to assess the effect of virgin coconut oil on cholesterol level and also will help to know whether virgin coconut oil can reduce the risk of heart diseases or not.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: All India Institute of Medical Sciences, Bhubaneswar
• Collaborator: Coconut Development Board, Government of India
• Treatments: Atorvastatin

Criteria

Inclusion Criteria:

• Patients with dyslipidemia [diagnosis of dyslipidemia is made when either of the lipid abnormality is present: LDL-C >140mg/dl, HDL-C <40mg/dl, Triglyceride >150mg/dl according to diagnostic criteria of dyslipidemia ]

• Patients aged 18-65 years, of either sex.

• Treatment-naive patients or patients who had not taken any treatment for at least 2 weeks before inclusion.

Exclusion Criteria:

• History of any cardiovascular diseases, stroke, diabetes, malignancy, musculoskeletal or hepatic diseases

• History of hypersensitivity to statins or coconut oil

• Patients who are already under treatment for the presenting conditions.

• Patients with drug/alcohol abuse.

• Pregnant and nursing women.